AML WITH GENE MUTATIONS
Clinical trials for AML WITH GENE MUTATIONS explained in plain language.
Never miss a new study
Get alerted when new AML WITH GENE MUTATIONS trials appear
Sign up with your email to follow new studies for AML WITH GENE MUTATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare leukemia: targeted combo trial launches
Disease control Recruiting nowThis early-phase trial tests a new drug called revumenib alongside standard chemotherapy and a targeted therapy (midostaurin) for adults with a specific genetic form of acute myeloid leukemia (AML). The goal is to find a safe dose that improves remission rates. About 22 newly dia…
Matched conditions: AML WITH GENE MUTATIONS
Phase: PHASE1 • Sponsor: Richard Stone, MD • Aim: Disease control
Last updated May 17, 2026 06:13 UTC
-
New hope for leukemia patients: experimental drug targets resistant cancers
Disease control Recruiting nowThis early-stage study tests a new drug, ZE46-0134, in adults with a hard-to-treat form of acute myeloid leukemia (AML) that has come back or not responded to standard treatment. The goal is to find a safe dose and see if the drug can shrink or control the cancer. About 150 parti…
Matched conditions: AML WITH GENE MUTATIONS
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC